
Nadifloxacin is a potent, broad-spectrum fluoroquinolone antibiotic specifically developed for topical applications. Zyntex provides this high-purity API for effective treatment of acne vulgaris and various bacterial skin infections.
In the treatment of inflammatory skin conditions, the precision of the antibiotic agent is vital for clinical success. Zyntex Nadifloxacin is selected for its robust activity against Propionibacterium acnes and Staphylococcus aureus. It functions by inhibiting bacterial DNA gyrase, which effectively stops bacterial replication without causing significant systemic absorption. Therefore, we utilize advanced synthesis protocols to maintain a high purity profile, ensuring that your dermatological products deliver targeted results with minimal irritation.
Zyntex supplies Nadifloxacin in a premium micronized powder form, optimized for easy dispersion in semi-solid vehicles. Our stringent quality control measures ensure a high assay value and minimal residual impurities, meeting the rigorous standards of global pharmacopoeias. Furthermore, this API features excellent chemical stability in various topical bases. Since it maintains its potency in diverse emulsion systems, you can incorporate it into advanced acne treatments or specialized wound care products with complete confidence in the final shelf-life and efficacy.
From specialized dermatological research to large-scale pharmaceutical manufacturing, this topical quinolone is a cornerstone for modern skin-health therapies. Its unique pharmacological profile allows for high local concentrations, leading to faster resolution of skin lesions. As a result, Zyntex provides a dependable foundation for innovation in the “medical-dermatology” and “acne-therapy” markets. Finally, our commitment to comprehensive quality documentation and safety compliance helps your brand navigate international regulatory pathways seamlessly.
This professional-grade antibiotic API is widely utilized in the following sectors:
The primary active ingredient for prescription creams and gels targeting inflammatory acne vulgaris.
Used in topical ointments for the treatment of folliculitis, sycosis vulgaris, and impetigo.
Essential reagent for microbiological studies focusing on antibiotic resistance in skin pathogens.
Applied in the development of complex dermatological delivery systems for enhanced local absorption.
| Parameter | Specification Standard |
|---|---|
| Product Name | Nadifloxacin |
| Grade | Pharmaceutical Grade |
| Purity (Assay) | Minimum 99.0% |
| Appearance | White to Pale Yellow Powder |
| CAS Number | 124858-35-1 |
🔬 Scientific Data: For detailed chemical and pharmacological data, consult: PubChem Entry: Nadifloxacin (External Link)